Format

Send to

Choose Destination
Blood. 2001 May 1;97(9):2900-2.

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Author information

1
Department of Immunology, The Medical School, University of Birmingham, England.

Abstract

Using sensitive, automated immunoassays, increased concentrations of either kappa or lambda free light chains (and abnormal kappa/lambda ratios) were detected in the sera of 19 of 28 patients with nonsecretory multiple myeloma. Four other patients had suppression of one or both light chains, and the remaining 5 sera had normal or raised free light-chain concentrations with substantially normal kappa/lambda ratios. Six of the patients with an elevated single free light chain, who were studied during follow-up, had changes in disease activity that were reflected by the changes in free light-chain concentrations. It is concluded that quantification of free light chains in serum should prove useful for the diagnosis and monitoring of many patients with nonsecretory myeloma.

PMID:
11313287
DOI:
10.1182/blood.v97.9.2900
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center